Cytrx Corp (NASDAQ:CYTR)

CAPS Rating: 2 out of 5

A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.

Recs

0
Player Avatar onesweetworld (32.05) Submitted: 2/21/2007 12:14:42 PM : Outperform Start Price: $31.11 CYTR Score: -85.08

big opps

Featured Broker Partners


Advertisement